David Beier Insider Profile
4 Followers
David Beier, Director at Infinity Pharmaceuticals, holds 8.78K shares in Infinity Pharmaceuticals (Ticker: INFIQ), holds 35.61K shares in Amgen (Ticker: AMGN), holds ― shares in Arcus Biosciences (Ticker: RCUS).
David Beier's Trading History
You May Also Like
David Beier insider profile FAQ
What is the percentage of profitable transactions made by David Beier?
The percentage of profitable transactions made by David Beier is 0%.
What is the average return per transaction made by David Beier?
The average return per transaction made by David Beier is -36.40%.
What stocks does David Beier hold?
David Beier holds: INFIQ, AMGN, RCUS stocks.
What was David Beier’s latest transaction?
David Beier’s latest transaction was an Uninformative Buy of $10.50K.
What was David Beier's most profitable transaction?
David Beier’s most profitable transaction was an Informative Sell of AMGN stock on June 5, 2009. The return on the trade was -6.70%.
What is David Beier's role in Infinity Pharmaceuticals?
David Beier's role in Infinity Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
